ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,898 | -3.0% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $48,339 | -99.1% | 13,100 | -99.2% | 0.00% | -99.3% |
| Q1 2023 | $5,273,161 | -48.5% | 1,593,100 | -39.6% | 0.14% | -47.2% |
| Q4 2022 | $10,239,708 | +72.0% | 2,639,100 | +7.7% | 0.26% | +66.7% |
| Q3 2022 | $5,954,000 | +1042.8% | 2,450,300 | +831.3% | 0.16% | +1225.0% |
| Q2 2022 | $521,000 | +8.3% | 263,100 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $481,000 | +2572.2% | 263,100 | +1908.4% | 0.01% | – |
| Q4 2021 | $18,000 | -93.9% | 13,100 | -95.0% | 0.00% | -100.0% |
| Q3 2021 | $297,000 | -48.9% | 263,100 | -27.5% | 0.01% | -40.0% |
| Q2 2021 | $581,000 | -39.2% | 363,100 | -33.1% | 0.01% | -44.4% |
| Q1 2021 | $956,000 | – | 543,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |